Insider Trading: Genomic Health Inc (GHDX.O)
GHDX.O on Nasdaq
37.25USD
17 May 2013
37.25USD
17 May 2013
Price Change (% chg)
$0.70 (+1.92%)
$0.70 (+1.92%)
Prev Close
$36.55
$36.55
Open
$36.68
$36.68
Day's High
$37.36
$37.36
Day's Low
$36.68
$36.68
Volume
244,690
244,690
Avg. Vol
222,772
222,772
52-wk High
$37.44
$37.44
52-wk Low
$25.25
$25.25
COLE GORDON BRADLEY
| Trading Date | Type | Shares Traded | Price | Shares Held |
|---|---|---|---|---|
| 7 May 2013 | Buy | 2,500 | $1.33 | 13,540 |
| 7 May 2013 | Sell | 2,500 | $35.99 | 13,540 |
| 2 Apr 2013 | Sell | 2,500 | $27.79 | 13,540 |
| 2 Apr 2013 | Buy | 2,500 | $1.33 | 13,540 |
| 5 Mar 2013 | Buy | 2,500 | $1.33 | 13,540 |
| 5 Mar 2013 | Sell | 2,500 | $28.57 | 13,540 |
| 14 Feb 2013 | Sell | 846 | $28.77 | 13,266 |
| 14 Feb 2013 | Sell | 973 | $28.77 | 13,266 |
| 5 Feb 2013 | Sell | 2,500 | $28.03 | 15,085 |
| 5 Feb 2013 | Buy | 2,500 | $1.33 | 15,085 |
| 8 Jan 2013 | Sell | 2,500 | $27.88 | 15,085 |
| 8 Jan 2013 | Buy | 2,500 | $1.33 | 15,085 |
| 5 Dec 2012 | Sell | 2,500 | $27.18 | 15,085 |
| 5 Dec 2012 | Buy | 2,500 | $1.33 | 15,085 |
| 7 Nov 2012 | Buy | 2,500 | $1.33 | 15,085 |
| 7 Nov 2012 | Sell | 2,500 | $28.62 | 15,085 |
| 8 Oct 2012 | Buy | 2,500 | $1.33 | 15,085 |
| 8 Oct 2012 | Sell | 2,500 | $34.80 | 15,085 |
| 5 Sep 2012 | Buy | 2,500 | $1.33 | 15,085 |
| 5 Sep 2012 | Sell | 2,500 | $35.01 | 15,085 |
| 7 Aug 2012 | Buy | 2,500 | $1.33 | 15,085 |
| 7 Aug 2012 | Sell | 2,500 | $30.49 | 15,085 |
| 4 Jul 2012 | Sell | 2,500 | $35.95 | 15,085 |
| 4 Jul 2012 | Buy | 2,500 | $1.33 | 15,085 |
| 5 Jun 2012 | Sell | 2,500 | $33.97 | 14,507 |
Institutional Holders
| % Shares Owned: | 0.00% |
| # of Holders: | 151 |
| Total Shares Held: | 40,919,598 |
| 3 Mo. Net Change: | 707,192 |
| # New Positions: | 21 |
| # Closed Positions: | 25 |
| # Increased Positions: | 73 |
| # Reduced Positions: | 68 |
| # Net Buyers: | 5 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Kimberly Popovits |
54 | 2012 | Chairman of the Board, President, Chief Executive Officer |
Dean Schorno |
50 | 2011 | Chief Financial Officer |
G. Bradley Cole |
57 | 2012 | Chief Operating Officer |
Steven Shak |
62 | 2012 | Executive Vice President - Research and Development, Chief Medical Officer |
Kathy Hibbs |
49 | 2012 | Senior Vice President, General Counsel, Secretary |
Julian Baker |
45 | 2012 | Lead Independent Director |
Felix Baker |
44 | 2012 | Director |
Fred Cohen |
56 | 2002 | Independent Director |
Samuel Colella |
2001 | Independent Director | |
Ginger Graham |
56 | 2008 | Independent Director |
Randall Livingston |
58 | 2004 | Independent Director |
Woodrow Myers |
58 | 2006 | Independent Director |

